Evaxion A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
3.711
+0.161 (4.53%)
Jun 8, 2026, 2:16 PM EDT - Market open
Evaxion Market Cap
Evaxion has a market cap or net worth of $30.95 million as of June 8, 2026. Its market cap has increased by 183.21% in one year.
Market Cap
30.95M
Enterprise Value
11.17M
1-Year Change
183.21%
Ranking
Category
Stock Price
$3.71
Market Cap Chart
Since the IPO on February 5, 2021, Evaxion's market cap has decreased from $191.99M to $30.95M, a decrease of -83.88%. That is a compound annual growth rate of -28.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 29.61M | -25.58% |
| Dec 31, 2025 | 39.78M | 702.21% |
| Dec 31, 2024 | 4.96M | -80.92% |
| Dec 29, 2023 | 25.99M | -39.34% |
| Dec 30, 2022 | 42.84M | -58.12% |
| Dec 31, 2021 | 102.29M | -46.72% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Boundless Bio | 31.83M |
| NanoViricides | 31.44M |
| Apollomics | 30.74M |
| Aligos Therapeutics | 30.38M |
| Lisata Therapeutics | 30.26M |
| Senti Biosciences Holdings | 30.07M |
| IGC Pharma | 28.26M |
| Daré Bioscience | 28.16M |